重组DNA
实时聚合酶链反应
基因组DNA
分子生物学
底漆(化妆品)
聚合酶链反应
分析灵敏度
生物
DNA
底漆二聚体
检出限
大肠杆菌
DNA提取
化学
色谱法
基因
生物化学
多重聚合酶链反应
医学
病理
有机化学
替代医学
作者
Jenq-Sheng Chang,Yu‐Chen Chen,Yu‐Chi Chou,Shih-Rong Wang
出处
期刊:Biologicals
[Elsevier]
日期:2014-03-01
卷期号:42 (2): 74-78
被引量:5
标识
DOI:10.1016/j.biologicals.2013.10.005
摘要
All biological products are derived from complex living systems and are often mixed with large numbers of impurities. For reasons of safety, residual host-cell DNA must be eliminated during processing. To assay host-cell DNA content in biopharmaceutical products derived from porcine sources, this study applies the quantitative real-time polymerase chain reaction (Q-PCR) method. The optimized assay in this study is based on the pol region of the porcine endogenous retrovirus (PERV). Assay validation results demonstrate that the proposed assay has appropriate accuracy, preciseness, reproducibility, and sensitivity. Primer and probe specificity are evaluated in real-time Q-PCR reactions using genomic DNA from rabbit, mouse, cat, hamster, monkey, human cell, yeast, and Escherichia coli as templates. The sensitivity of real-time Q-PCR is determined using genomic DNA from the porcine kidney cell line. The reliable detection range is within 0.5–105 pg/reaction. The limit of quantitation is 500 fg. The sensitivity of the assay meets the authority criterion. Moreover, the assay is applied to determine the level of host-cell DNA in recombinant human coagulation factor IX (rhFIX) from transgenic pigs. The real-time Q-PCR assay is thus a promising new tool for quantitative detection and clearance validation of residual porcine DNA when manufacturing recombinant therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI